Indogulf Cropsciences Ltd
Incorporated in 1993, Indogulf Cropsciences Limited is engaged in manufacturing crop protection products, plant nutrients, and biologicals in India.[1]
- Market Cap ₹ 531 Cr.
- Current Price ₹ 84.0
- High / Low ₹ 122 / 78.5
- Stock P/E 17.0
- Book Value ₹ 69.4
- Dividend Yield 0.00 %
- ROCE 13.2 %
- ROE 12.2 %
- Face Value ₹ 10.0
Pros
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of 3.78% over past five years.
- Company has a low return on equity of 12.8% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Fertilizers & Agrochemicals Pesticides & Agrochemicals
Part of BSE IPO
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| 492 | 443 | 486 | 551 | 553 | 592 | |
| 457 | 404 | 442 | 501 | 493 | 528 | |
| Operating Profit | 35 | 39 | 45 | 49 | 60 | 64 |
| OPM % | 7% | 9% | 9% | 9% | 11% | 11% |
| 3 | 2 | 4 | 1 | -2 | 6 | |
| Interest | 5 | 5 | 6 | 11 | 12 | 14 |
| Depreciation | 5 | 6 | 8 | 8 | 9 | 10 |
| Profit before tax | 28 | 31 | 36 | 31 | 36 | 45 |
| Tax % | 28% | 26% | 26% | 26% | 21% | 29% |
| 20 | 23 | 26 | 23 | 29 | 32 | |
| EPS in Rs | 52.30 | 9.77 | 11.26 | 9.80 | 12.19 | 6.58 |
| Dividend Payout % | 10% | -0% | -0% | -0% | -0% | -0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 4% |
| 3 Years: | 7% |
| TTM: | 7% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 9% |
| 3 Years: | 6% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 14% |
| 3 Years: | 13% |
| Last Year: | 12% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 4 | 24 | 24 | 24 | 24 | 49 | 63 |
| Reserves | 127 | 131 | 157 | 180 | 209 | 228 | 376 |
| 92 | 79 | 102 | 189 | 155 | 222 | 204 | |
| 150 | 178 | 139 | 121 | 154 | 183 | 214 | |
| Total Liabilities | 373 | 411 | 421 | 513 | 541 | 682 | 856 |
| 47 | 51 | 53 | 65 | 44 | 47 | 47 | |
| CWIP | 4 | 6 | 9 | 9 | 22 | 57 | 67 |
| Investments | 3 | 3 | 0 | 0 | 0 | 0 | 15 |
| 319 | 352 | 359 | 440 | 474 | 578 | 727 | |
| Total Assets | 373 | 411 | 421 | 513 | 541 | 682 | 856 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| -17 | 20 | -9 | 31 | 36 | -12 | |
| -35 | -10 | -10 | -0 | -0 | -40 | |
| 52 | -9 | 20 | -0 | -0 | 58 | |
| Net Cash Flow | 0 | 1 | 0 | 31 | 36 | 6 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Debtor Days | 88 | 97 | 115 | 117 | 146 | 140 |
| Inventory Days | 154 | 205 | 167 | 201 | 195 | 229 |
| Days Payable | 96 | 138 | 111 | 79 | 109 | 116 |
| Cash Conversion Cycle | 147 | 164 | 171 | 239 | 231 | 253 |
| Working Capital Days | 51 | 62 | 86 | 94 | 114 | 114 |
| ROCE % | 16% | 16% | 12% | 13% | 13% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Change in Management
20h - Deepak Tuli appointed VP‑Accounts; Surinder Kumar resigned as VP‑Sales, effective December 13, 2025.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
26 Nov - Virtual analyst/institutional investor meetings on Dec 01, 2025 at 11:00 AM IST.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
25 Nov - Of Schedule of Analyst / Institutional Investor Meetings under Regulation 30 of the SEBI (LODR) Regulations, 2015
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
19 Nov - Submission of the Transcript of Q2 FY 2025-26 Earning Conference Call Held on 13th November 2025
-
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
14 Nov - Monitoring agency report for quarter ended Sep 30, 2025; IPO proceeds Rs200 crore raised; no deviations.
Annual reports
Concalls
-
Nov 2025Transcript PPT
-
Aug 2025Transcript PPT
Business Profile[1]
Indogulf Cropsciences Limited is an agrochemical company engaged in the manufacturing and marketing of crop protection products, plant nutrients, and biologicals. It operates across India and exports to over 34 countries. It serves both retail (B2C) and institutional (B2B) customers and also offers contract manufacturing services.